Chemical Formula: C25H43N13O10
Chemical Formula C25H43N13O10
Found 9 metabolite its formula value is C25H43N13O10
Viomycin
Tuberactinomycin B; Vinacetin A; Vioactane
A cyclic peptide antibiotic produced by the actinomycete Streptomyces puniceus, used in the treatment of tuberculosis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
3,6-diamino-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-amino-(2-amino-6-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl-(1->N3)]|Viomycin
3,6-diamino-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-amino-(2-amino-6-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl-(1->N3)]|Viomycin
Enviomycin
3,6-diamino-N-[(6Z)-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C258 - Antibiotic
(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
(3s,4r)-3,6-diamino-4-hydroxy-n-[(3s,6e,9r,12s,15s)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4s)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
(3s,4r)-3,6-diamino-4-hydroxy-n-[(3s,6e,9r,12s,15s)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4s)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
3,6-diamino-4-hydroxy-n-[(3r,6z)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-(2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid
3,6-diamino-4-hydroxy-n-[(3r,6z)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-(2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid